{{Rsnum
|rsid=17329669
|Chromosome=7
|position=36812324
|Orientation=plus
|GMAF=0.07668
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 64.6 | 35.4 | 0.0
| HCB | 100.0 | 0.0 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 90.5 | 9.5 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 100.0 | 0.0 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}rs17329669 increases susceptibility to Parkinson's disease 1.71 times for carriers of the G allele {{PMID|16252231|OA=1
}}

{{PMID|16685661|OA=1
}} Genomewide association, Parkinson disease, and PARK10.

{{PMID|16685662|OA=1
}} No evidence for association with Parkinson disease for 13 single-nucleotide polymorphisms identified by whole-genome association screening.

{{PMID|16685663|OA=1
}} A case-control association study of the 12 single-nucleotide polymorphisms implicated in Parkinson disease by a recent genome scan.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}